219 related articles for article (PubMed ID: 25707772)
21. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways.
An SM; Ding Q; Zhang J; Xie J; Li L
Sci China Life Sci; 2014 Jun; 57(6):575-80. PubMed ID: 24829106
[TBL] [Abstract][Full Text] [Related]
22. Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies.
Stella GM; Luisetti M; Inghilleri S; Cemmi F; Scabini R; Zorzetto M; Pozzi E
Respir Med; 2012 Feb; 106(2):173-83. PubMed ID: 22104541
[TBL] [Abstract][Full Text] [Related]
23. [Responses to targeted therapies: lung cancer].
Brambilla E
Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
[No Abstract] [Full Text] [Related]
24. Advances in treatment of lung cancer with targeted therapy.
Cagle PT; Chirieac LR
Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance.
Asghariazar V; Sakhinia E; Mansoori B; Mohammadi A; Baradaran B
J Cell Biochem; 2019 Dec; 120(12):19274-19289. PubMed ID: 31364210
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
27. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
28. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
29. Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.
Riess JW; Wakelee HA
Clin Adv Hematol Oncol; 2012 Apr; 10(4):226-34. PubMed ID: 22706483
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells and the ontogeny of lung cancer.
Peacock CD; Watkins DN
J Clin Oncol; 2008 Jun; 26(17):2883-9. PubMed ID: 18539968
[TBL] [Abstract][Full Text] [Related]
31. Molecular histology of lung cancer: from targets to treatments.
Wood SL; Pernemalm M; Crosbie PA; Whetton AD
Cancer Treat Rev; 2015 Apr; 41(4):361-75. PubMed ID: 25825324
[TBL] [Abstract][Full Text] [Related]
32. Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies.
Alexander PB; Wang XF
Front Med; 2015 Jun; 9(2):134-8. PubMed ID: 25957263
[TBL] [Abstract][Full Text] [Related]
33. Regulation of signal transduction cascades by Pterostilbenes in different cancers: Is it a death knell for oncogenic pathways.
Butt G; Attar R; Tabassum S; Aras A; Qadir MI; Ozbey U; Alaaeddine N; Ozcelik B; Farooqi AA
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):5-10. PubMed ID: 29307345
[TBL] [Abstract][Full Text] [Related]
34. Nitric Oxide and Aggressive Behavior of Lung Cancer Cells.
Luanpitpong S; Chanvorachote P
Anticancer Res; 2015 Sep; 35(9):4585-92. PubMed ID: 26254346
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review).
Rong B; Yang S
Int J Oncol; 2018 Feb; 52(2):321-336. PubMed ID: 29207057
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer.
Ning Y; Zheng H; Zhan Y; Liu S; Yang Y; Zang H; Luo J; Wen Q; Fan S
J Exp Clin Cancer Res; 2020 Aug; 39(1):162. PubMed ID: 32807223
[TBL] [Abstract][Full Text] [Related]
37. Intersections of lung progenitor cells, lung disease and lung cancer.
Kim CF
Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28659499
[TBL] [Abstract][Full Text] [Related]
38. Targeting apoptotic signaling pathways in human lung cancer.
Han SW; Roman J
Curr Cancer Drug Targets; 2010 Sep; 10(6):566-74. PubMed ID: 20482489
[TBL] [Abstract][Full Text] [Related]
39. Molecular origins of lung cancer: prospects for personalized prevention and therapy.
Haura EB; Camidge DR; Reckamp K; Chiappori A; Johnson F; Herbst R; Wong K; Carbone D
J Thorac Oncol; 2010 Jun; 5(6 Suppl 3):S207-13. PubMed ID: 20502275
[TBL] [Abstract][Full Text] [Related]
40. Key signaling pathways and targets in lung cancer therapy.
Choong NW; Salgia R; Vokes EE
Clin Lung Cancer; 2007 Feb; 8 Suppl 2():S52-60. PubMed ID: 17382025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
